Insulin analogs versus human insulin in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 93, Issue SUPPL. 1, 2011, Pages

  Migdalis, Ilias N ^a  

^a NIMTS HOSPITAL   (Greece)

Author keywords

Diabetes mellitus type 2; Human insulin; Insulin analogs; Insulin therapy

Indexed keywords

BIPHASIC INSULIN; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE;

ARTICLE; BEDTIME DOSAGE; BOLUS INJECTION; CLINICAL EFFECTIVENESS; DRUG DOSE TITRATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; WEIGHT GAIN;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; INSULIN, LONG-ACTING; WEIGHT GAIN;

EID: 84860408576     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70023-7     Document Type: Article

References (15)

1. Brunton S Insulin regimens for type 2 diabetes mellitus. J Fam Pract 2006, 55:10S-107.
2. Owens DR, Zinman B, Bolli GB Insulins today and beyond. Lancet 2001, 358:739-746.
3. Peterson GE Intermediate and long-acting insulin: a review of NPH insulin, insulin glargine and insulin detemir. Curr Med Res Opin 2006, 22:2613-2619.
4. Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006, 28:1569-1581.
5. Garg SK, Naik RG Long-acting insulin analogs versus human insulins. Diabetes Techn Ther 2008, 10:331-332.
6. Riddle MC, Rosenstock J, Gerich J The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003, 26:3080-3086.
7. Hermansen K, Davies M, Derezinski T, Ravn GM, Clauson P, Home P A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy as oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetes Care 2006, 29:1269-1274.
8. Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G A randomised 52 week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetologia 2008, 51:408-416.
9. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A Reduced hypoglycaemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005, 28:950-955.
10. Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007, 2. CD005613.
11. Monami M, Marchionni N, Mannucci E Long-acting insulin analogues versus NPH human insulin in type 2 diabetes. A meta-analysis. Diabetes Res Clin Pract 2008, 81:184-189.
12. Plank J, Siebenhofer A, Berghold A, Jeitler K, Horvath K, Mrak P, et al. Systemic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med 2005, 165:1337-1344.
13. Raccah D, Bretzel RG, Owens D, Riddle M When basal insulin therapy in type 2 diabetes mellitus is not enough -what next?. Diabetes Metab Res Rev 2007, 23:257-264.
14. Shah S, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, et al. Safety and effectiveness of biphasic insulin aspart 30/70 (NOVOMIX 30) when switching from human penmix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE(tm) observational study. Int J Clin Pract 2009, 63:574-582.
15. Lingvay L, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes. Diabetes Care 2009, 32:1789-1795.